Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06397911
Status:
RECRUITING
Last Update Posted:
2024-05-08
First Post:
2024-04-30
Brief Title:
Evaluate Efficacy Pharmacokinetics and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
Sponsor:
Oneness Biotech Co Ltd
Organization:
Oneness Biotech Co Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Atopic Dermatitis |
Keywords: